Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents

被引:46
作者
Al-Abdullah, Ebtehal S. [1 ]
Al-Obaid, Abdul-Rahman M. [1 ]
Al-Deeb, Omar A. [1 ]
Habib, Elsayed E. [2 ]
El-Emam, Ali A. [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] Univ Mansoura, Fac Pharm, Dept Microbiol, Mansoura 35516, Egypt
关键词
Pyrimidines; Dihydro-4-oxopyrimidine; Antimicrobial activity; REVERSE-TRANSCRIPTASE INHIBITORS; DIHYDROFOLATE-REDUCTASE INHIBITOR; ONE-STEP SYNTHESIS; ETHYL CYANOACETATE; NUCLEOSIDE ANALOGS; ANTIVIRAL AGENTS; IN-VITRO; DERIVATIVES; DESIGN; PYRIMIDINES;
D O I
10.1016/j.ejmech.2011.08.003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New series of 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles namely, 2-substitued thio-6-phenyl-3,4-dihydro-4-oxopyrimidine-5-carbonitriles (5a-d, 6, 7a-d, 8), 2-(4-chlorobenzylthio)-4-chloro-6-phenylpyrimidine-5-carbonitrile (9), 2-(4-chlorobenzylthio)-4-arylthio-6-phenylpyrimidine-5-carbonitriles (10a-d) and 2-(4-chlorobenzylthio)-4-arylamino-6-phenylpyrimidine-5-carbonitriles (11a-d) was synthesized and tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compounds 5b, 5c, 6, 7a, 7b, 7c, 9 and 11a displayed marked antibacterial activity particularly against the tested Gram-positive bacteria, while compounds 6, 7c, 7d and 9 were moderately or weakly active against C. albicans. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4642 / 4647
页数:6
相关论文
共 54 条
[1]   Suitably functionalised pyrimidines as potential antimycotic agents [J].
Agarwal, N ;
Raghuwanshi, SK ;
Upadhyay, DN ;
Shukla, PK ;
Ram, VJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (08) :703-706
[2]  
AKIMOTO T, 1969, FOLIA PHARMACOL JPN, V65, P378
[3]   5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens [J].
Al Safarjalani, ON ;
Zhou, XJ ;
Rais, RH ;
Shi, JX ;
Schinazi, RF ;
Naguib, FNM ;
el Kouni, MH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :541-551
[4]   Some Observations on the Base-Catalyzed Cyclocondensation of 2,6-Dihalobenzaldehydes, Ethyl Cyanoacetate, and Thiourea [J].
Al-Omar, Mohamed A. ;
Al-Obaid, Abdul-Rahman M. ;
El-Brollosy, Nasser R. ;
El-Emam, Ali A. .
SYNTHETIC COMMUNICATIONS, 2010, 40 (10) :1530-1538
[5]   3,4-DIHYDRO-2-ALKOXY-6-BENZYL-4-OXOPYRIMIDINES (DABOS) - A NEW CLASS OF SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ARTICO, M ;
MASSA, S ;
MAI, A ;
MARONGIU, ME ;
PIRAS, G ;
TRAMONTANO, E ;
LACOLLA, P .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (06) :361-368
[6]  
Basavaraja H S., 2010, J. Pharm. Sci. Res, V2, P5
[7]  
BLOKHINA NG, 1972, CANCER-AM CANCER SOC, V30, P390, DOI 10.1002/1097-0142(197208)30:2<390::AID-CNCR2820300214>3.0.CO
[8]  
2-E
[9]   PHARMACOLOGICAL STUDIES WITH SK AND F-93944 (TEMELASTINE), A NOVEL HISTAMINE H-1-RECEPTOR ANTAGONIST WITH NEGLIGIBLE ABILITY TO PENETRATE THE CENTRAL-NERVOUS-SYSTEM [J].
BROWN, EA ;
GRIFFITHS, R ;
HARVEY, CA ;
OWEN, DAA .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (03) :569-578
[10]   REASSESSMENT OF THE RATIONALE FOR THE COMBINATIONS OF SULFONAMIDES WITH DIAMINOPYRIMIDINES [J].
BRUMFITT, W ;
HAMILTONMILLER, JMT .
JOURNAL OF CHEMOTHERAPY, 1993, 5 (06) :465-469